ARCHIVES

In Brief: NIH Conference To Explore Conflict Of Interest Issues; Five NCUI Executive Win PHS Awards

This article is from The Cancer Letter archive.

Vol. 15 No. 21 | May 26, 1989

Download PDF Visit The Full Archive

Related Articles

Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says.

May 7, 2004

Senate committee approves Lester Crawford’s nomination for FDA Commissioner.

June 17, 2005

Stronger Anti-Smoking Efforts Needed For Women, SG Says.

March 30, 2001

Guest Editorial: Don Berry On Cancer Centers Publishing Comparative Survival Data

March 18, 2011

FDA Approves Kytril For Post-Operative Nausea

October 25, 2002

IOM Recommends FDA Consolidate Each Drug’s Lifetime History

May 4, 2012